AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 117 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,179,000 | +122.9% | 186,823 | +4.6% | 0.00% | +200.0% |
| Q3 2019 | $5,015,000 | -20.4% | 178,549 | +7.3% | 0.00% | -50.0% |
| Q2 2019 | $6,302,000 | +1.6% | 166,441 | +4.7% | 0.00% | 0.0% |
| Q1 2019 | $6,202,000 | +91.1% | 158,933 | +4.4% | 0.00% | +100.0% |
| Q4 2018 | $3,245,000 | -35.9% | 152,232 | +19.1% | 0.00% | 0.0% |
| Q3 2018 | $5,059,000 | +3.7% | 127,770 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $4,879,000 | +68.1% | 127,693 | +32.1% | 0.00% | 0.0% |
| Q1 2018 | $2,903,000 | +12.7% | 96,645 | +17.3% | 0.00% | 0.0% |
| Q4 2017 | $2,575,000 | +68.0% | 82,409 | +50.6% | 0.00% | – |
| Q3 2017 | $1,533,000 | +51.5% | 54,722 | +3.4% | 0.00% | – |
| Q2 2017 | $1,012,000 | +215.3% | 52,900 | +180.7% | 0.00% | – |
| Q1 2017 | $321,000 | +26.9% | 18,843 | +36.2% | 0.00% | – |
| Q4 2016 | $253,000 | – | 13,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |